Gilead Sciences announced plans Monday to start testing an inhaled version of its experimental coronavirus drug to determine whether it could treat the deadly disease sooner. The pharma giant will …
Gilead to Start Testing Inhaled Version of Remdesivi
Comment
Show comments
Hide Comments
